Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.
Ontology highlight
ABSTRACT: With increasing age, as the incidence of Alzheimer's disease is increasing, finding a therapeutic intervention is becoming critically important to either prevent or slow down the progression of the disease. Passive immunotherapy has been demonstrated as a successful way of reducing large aggregates and improving cognition in animal models of both tauopathies and Alzheimer's disease. However, with all the continuous attempts and significant success of immunotherapy in preclinical studies, finding a successful clinical therapy has been a great challenge, possibly indicating a lack of accuracy in targeting the toxic species. Both active and passive immunotherapy approaches in transgenic animals have been demonstrated to have pros and cons. Passive immunotherapy has been favored and many mecha
SUBMITTER: Bittar A
PROVIDER: S-EPMC5829136 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA